Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q3 2024 (September 30)8holders −11
2new positions
13sold out
$1.08avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 11 from Q2 2024. 2 opened new positions and 13 sold out. The largest holders were Vestcor Inc ($74K), Foster Victor Wealth Advisors, LLC ($33K) and HRT Financial LP ($29K).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q3 2024)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 13 | $3.3M |
All 13F filers, Q2 2024 → Q3 2024: 28,883 shares bought and 1,997,595 shares sold, net −1,968,712 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Vestcor Inc | — | Reduce -52.4% | 70,832 | $74K |
| Foster Victor Wealth Advisors, LLC | — | Add +4.7% | 22,158 | $33K |
| HRT Financial LP | — | Reduce -5.6% | 28,250 | $29K |
| B & T Capital Management DBA Alpha Capital Management | — | No change | 22,222 | $22K |
| Cowen and Company, LLC | — | No change | 20,369 | $21K |
| Wolverine Asset Management LLC | — | New | 14,751 | $15K |
| GTS Securities LLC | — | New | 13,132 | $14K |
| Tower Research Capital LLC (TRC) | — | No change | 42 | $42 |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.